Let's Embrace Optical Imaging: a Growing Branch on the Clinical Molecular Imaging Tree

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2021 Aug 31

PMID 34463808

Citations 9

Authors

Milou E Noltes

Gooitzen M van Dam

Wouter B Nagengast

Pieter J van der Zaag

Riemer H J A Slart

Wiktor Szymanski

Schelto Kruijff

Rudi A J O Dierckx

Affiliations

Soon will be listed here.

Citing Articles

Why and how optical molecular imaging should further be catalyzed by nuclear medicine and molecular imaging: report from the EANM piloting group.

Vonk J, Dierckx R, Keereweer S, Vahrmeijer A, Verburg F, Kruijff S Eur J Nucl Med Mol Imaging. 2024; 51(12):3501-3504.

PMID: 38787394 DOI: 10.1007/s00259-024-06729-3.

Noninvasive Visualization of Amyloid-Beta Deposits in Alzheimer's Amyloidosis Mice via Fluorescence Molecular Tomography Using Contrast Agent.

Ren W, Ni R Methods Mol Biol. 2024; 2785:271-285.

PMID: 38427199 DOI: 10.1007/978-1-0716-3774-6_16.

Shedding light on ultrasound in action: Optical and optoacoustic monitoring of ultrasound brain interventions.

Karakatsani M, Estrada H, Chen Z, Shoham S, Dean-Ben X, Razansky D Adv Drug Deliv Rev. 2024; 205:115177.

PMID: 38184194 PMC: 11298795. DOI: 10.1016/j.addr.2023.115177.

Biophotonics as a new application in optical technology: A bibliometric analysis.

Lam W, Lam W, Lee P, Jaaman S Heliyon. 2023; 9(12):e23011.

PMID: 38076099 PMC: 10703716. DOI: 10.1016/j.heliyon.2023.e23011.

quantification of programmed death-ligand-1 expression heterogeneity in tumors using fluorescence lifetime imaging.

Pal R, K M, Matsui A, Kang H, Morita S, Taniguchi H Res Sq. 2023; .

PMID: 37961361 PMC: 10635296. DOI: 10.21203/rs.3.rs-3222037/v1.

References

SEIDLIN S, MARINELLI L, OSHRY E . Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid. J Am Med Assoc. 2010; 132(14):838-47. DOI: 10.1001/jama.1946.02870490016004. View

KESTON A, Ball R, FRANTZ V, Palmer W . STORAGE OF RADIOACTIVE IODINE IN A METASTASIS FROM THYROID CARCINOMA. Science. 1942; 95(2466):362-3. DOI: 10.1126/science.95.2466.362. View

Blahd W . Ben Cassen and the development of the rectilinear scanner. Semin Nucl Med. 1996; 26(3):165-70. DOI: 10.1016/s0001-2998(96)80021-3. View

Cosgrove D, McCready V . Diagnosis of liver metastases using ultrasound and isotope scanning techniques. J R Soc Med. 1978; 71(9):652-7. PMC: 1436245. DOI: 10.1177/014107687807100905. View

Hutton B . The origins of SPECT and SPECT/CT. Eur J Nucl Med Mol Imaging. 2013; 41 Suppl 1:S3-16. DOI: 10.1007/s00259-013-2606-5. View

Wagner Jr H . A brief history of positron emission tomography (PET). Semin Nucl Med. 1998; 28(3):213-20. DOI: 10.1016/s0001-2998(98)80027-5. View

Slomka P, Pan T, Berman D, Germano G . Advances in SPECT and PET Hardware. Prog Cardiovasc Dis. 2015; 57(6):566-78. DOI: 10.1016/j.pcad.2015.02.002. View

van Sluis J, de Jong J, Schaar J, Noordzij W, van Snick P, Dierckx R . Performance Characteristics of the Digital Biograph Vision PET/CT System. J Nucl Med. 2019; 60(7):1031-1036. DOI: 10.2967/jnumed.118.215418. View

Richards P, Tucker W, Srivastava S . Technetium-99m: an historical perspective. Int J Appl Radiat Isot. 1982; 33(10):793-9. DOI: 10.1016/0020-708x(82)90120-x. View

10.

Cherry S, Jones T, Karp J, Qi J, Moses W, Badawi R . Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care. J Nucl Med. 2017; 59(1):3-12. PMC: 5750522. DOI: 10.2967/jnumed.116.184028. View

11.

Anand S, Singh H, Dash A . Clinical Applications of PET and PET-CT. Med J Armed Forces India. 2016; 65(4):353-8. PMC: 4921358. DOI: 10.1016/S0377-1237(09)80099-3. View

12.

SWEET W, Brownell G . Localization of intracranial lesions by scanning with positron-emitting arsenic. J Am Med Assoc. 1955; 157(14):1183-8. DOI: 10.1001/jama.1955.02950310009002. View

13.

Davis K, Ryan J, Aaron V, Sims J . PET and SPECT Imaging of the Brain: History, Technical Considerations, Applications, and Radiotracers. Semin Ultrasound CT MR. 2020; 41(6):521-529. DOI: 10.1053/j.sult.2020.08.006. View

14.

Basu S, Alavi A . PET-Based Personalized Management in Clinical Oncology: An Unavoidable Path for the Foreseeable Future. PET Clin. 2016; 11(3):203-7. DOI: 10.1016/j.cpet.2016.03.002. View

15.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

16.

Wagner Jr H . Clinical PET: its time has come. J Nucl Med. 1991; 32(4):561-4. View

17.

Klunk W, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt D . Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004; 55(3):306-19. DOI: 10.1002/ana.20009. View

18.

Ehrhardt Jr J, Gulec S . A Review of the History of Radioactive Iodine Theranostics: The Origin of Nuclear Ontology. Mol Imaging Radionucl Ther. 2020; 29(3):88-97. PMC: 7583745. DOI: 10.4274/mirt.galenos.2020.83703. View

19.

Kratochwil C, Giesel F, Bruchertseifer F, Mier W, Apostolidis C, Boll R . ²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience. Eur J Nucl Med Mol Imaging. 2014; 41(11):2106-19. PMC: 4525192. DOI: 10.1007/s00259-014-2857-9. View

20.

Virgolini I, Decristoforo C, Haug A, Fanti S, Uprimny C . Current status of theranostics in prostate cancer. Eur J Nucl Med Mol Imaging. 2017; 45(3):471-495. PMC: 5787224. DOI: 10.1007/s00259-017-3882-2. View